Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SUPN

Supernus

$38.05

-11.6 (-23.36%)

07:43
09/20/17
09/20
07:43
09/20/17
07:43
Recommendations
Supernus analyst commentary at Janney Capital »

Janney says Supernus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SUPN

Supernus

$38.05

-11.6 (-23.36%)

07:11
09/20/17
09/20
07:11
09/20/17
07:11
Recommendations
Supernus analyst commentary at Jefferies »

Jefferies still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Tuesday
SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

06:33
09/19/17
09/19
06:33
09/19/17
06:33
Conference/Events
Supernus management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

06:14
09/19/17
09/19
06:14
09/19/17
06:14
Downgrade
Supernus rating change at Stifel »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

Monday
SCS

Steelcase

$14.35

0.1 (0.70%)

, DRNA

Dicerna

$3.99

0.08 (2.05%)

17:31
09/18/17
09/18
17:31
09/18/17
17:31
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SCS

Steelcase

$14.35

0.1 (0.70%)

DRNA

Dicerna

$3.99

0.08 (2.05%)

NBRV

Nabriva Therapeutics

$8.87

2.01 (29.30%)

SUPN

Supernus

$49.65

0.6 (1.22%)

BECN

Beacon Roofing

$49.24

0.56 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 19

    Sep

  • 25

    Sep

  • 25

    Oct

  • 26

    Oct

  • 20

    Sep

  • 21

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

16:30
09/18/17
09/18
16:30
09/18/17
16:30
Hot Stocks
Breaking Hot Stocks news story on Supernus 

Supernus trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

16:17
09/18/17
09/18
16:17
09/18/17
16:17
Hot Stocks
Supernus announces interim analysis on SPN-810 trial, eliminates 18mg dose »

Supernus announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

SUPN

Supernus

16:00
09/18/17
09/18
16:00
09/18/17
16:00
Hot Stocks
Breaking Hot Stocks news story on Supernus »

Supernus trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

Over a month ago
SUPN

Supernus

$44.30

1.6 (3.75%)

07:56
08/16/17
08/16
07:56
08/16/17
07:56
Recommendations
Supernus analyst commentary at Jefferies »

Supernus legal win…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.